Human pituitary growth hormone and cancer risk
暂无分享，去创建一个
[1] M. Preece,et al. Risk of cancer in patients treated with human pituitary growth hormone in the UK, 1959–85: a cohort study , 2002, The Lancet.
[2] P. Poole‐Wilson,et al. Acquired growth hormone resistance in patients with chronic heart failure: implications for therapy with growth hormone. , 2001, Journal of the American College of Cardiology.
[3] T. Voigtländer,et al. Recombinant growth hormone therapy in patients with ischemic cardiomyopathy : effects on hemodynamics, left ventricular function, and cardiopulmonary exercise capacity. , 1999, Circulation.
[4] P. Ponikowski,et al. Wasting as independent risk factor for mortality in chronic heart failure , 1997, The Lancet.
[5] R. Ross,et al. Acquired growth hormone resistance. , 1995, European journal of endocrinology.